VTN and female reproductive organ cancer: Its activation can be induced by inflammatory growth factors and cytokines controlling the gynecological cancer development by involving in the degradation of the matrix including its components, vitronectin, fibronectin and collagen type I, which contribute to cancer cell adhesion and invasion [8, 22].